New guidelines for knee and hip replacements issued

Share this article:

New clinical treatment guidelines for preventing blood clots after hip or knee replacements emphasize preventive measures and caution against post-operative ultrasound tests.

The updated guidelines, released by the American Academy of Orthopaedic Surgeons, recommend that prior to surgery, patients should stop taking antiplatelet medications such as aspirin and Plavix. More than 800,000 Americans have hip or knee replacement surgeries each year.

Patients should not undergo post-operative ultrasound screening for thromboembolic disease, according to the guidelines, as this test does not significantly reduce the rate of symptomatic deep vein thrombosis or pulmonary embolism. The guidelines recommend that patients receive anticoagulant drug therapy, and encourage the use of mechanical compression devices to improve blood flow. Healthcare providers also should encourage patients to walk again as soon as possible.

Click here to read the full guidelines.


Share this article:

More in News

Long-term care continues to lead in deal volume and value: PwC report

Long-term care continues to lead in deal volume ...

Long-term care bucked healthcare industry trends with strong merger and acquisition activity in the second quarter of 2014, according to newly released data from professional services firm PricewaterhouseCoopers.

Empowering nurse practitioners could reduce hospitalizations from SNFs, study finds

Granting more authority to nurse practitioners is associated with reduced hospitalization of skilled nursing facility residents, according to recently published findings.

Pioneer ACO drops out of program, despite reductions in skilled nursing utilization

A California healthcare system has become the latest dropout from the Pioneer Accountable Care Organization program, despite reducing skilled nursing facility utilization and improving its readmission rates. Sharp HealthCare announced its decision in a quarterly financial statement released Tuesday.